Michael B. Jebsen
2018
In 2018, Michael B. Jebsen earned a total compensation of $855.8K as President and Chief Financial Officer at Tenax Therapeutics, a 44% increase compared to previous year.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Non-Equity Incentive Plan | $124,313 |
| Salary | $381,500 |
| Stock Awards | $175,000 |
| Total | $855,813 |
Jebsen received $381.5K in salary, accounting for 45% of the total pay in 2018.
Jebsen also received $175K in bonus, $124.3K in non-equity incentive plan and $175K in stock awards.
Rankings
In 2018, Michael B. Jebsen's compensation ranked 9,906th out of 14,244 executives tracked by ExecPay. In other words, Jebsen earned more than 30.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,906 out of 14,244 | 31st |
Division Manufacturing | 3,998 out of 5,759 | 31st |
Major group Chemicals And Allied Products | 1,500 out of 2,122 | 29th |
Industry group Drugs | 1,265 out of 1,811 | 30th |
Industry Pharmaceutical Preparations | 972 out of 1,385 | 30th |
Source: SEC filing on April 19, 2019.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2018.
2018
Anthony DiTonno
Tenax Therapeutics